Katie Levinson, MD

Katie Levinson is a Principal with the Commercial Strategy and Launch Excellence Practice at Acumetis. She uses natural curiosity, attention to detail, and analytical acumen when partnering with clients to develop pragmatic, innovative solutions to address critical business challenges. Her prior clinical training enables her to bring unique insight to commercial projects, seamlessly translating disease-state and healthcare-system knowledge into viable, winning strategies.

Katie has built deep expertise in numerous therapeutic areas, including cardiometabolic disorders, oncology, rare disease, dermatology, women’s health, and critical care, and has supported a wide variety of clients, ranging from small biotech startups to top-20 industry giants. During her tenure at Acumetis, Katie has guided over 20 new product, indication, and trade launches, led qualitative and quantitative landscape assessments, designed fit-for-purpose patient support programs, and overseen a variety of commercial strategic engagements such as business plans, go-to-market plans, and TA development frameworks.

Katie has completed residency training in Pathology and Laboratory Medicine, fellowship training in Surgical Pathology, and subspecialty fellowship training in Bone and Soft Tissue Pathology, all at the University of Pennsylvania. She also holds an M.D. from the Perelman School of Medicine at the University of Pennsylvania and a B.S. in Brain and Cognitive Sciences from the Massachusetts Institute of Technology.